PHARMAVEST ApS: Financial statements 2014
CVR: 26385180
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 926,252 and a net result of DKK 199,954 compared with DKK 415,767 the year before. That is a decrease of 35.5% compared with the year before. Equity in the 2014 report amounted to DKK 2,883,134. The solvency ratio was 81.4%.
- Gross Profit
- DKK 926,252
- Profit/Loss
- DKK 199,954
- Equity
- DKK 2,883,134
- Total Assets
- DKK 3,539,994
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 926 t. | 200 t. | 2.9 mio. | - |
| 2013 | - | 1.4 mio. | 416 t. | 2.8 mio. | - |
| 2012 | - | 1.6 mio. | 737 t. | 2.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMAVEST ApS has published its annual report for 2013. Gross profit came to DKK 1,435,221, and the net result was DKK 415,767.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.